• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国国家脂质协会针对美国一种非处方他汀类药物对消费者、医生和药剂师进行的调查:这是个好主意吗?

The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: is this a good idea?

作者信息

McKenney James M, Brown W Virgil, Cohen Jerome D, Cahill Edward

机构信息

National Clinical Research, Inc., Richmond, Virginia 23294-3740, USA.

出版信息

Am J Cardiol. 2004 Nov 4;94(9A):16F-21F. doi: 10.1016/j.amjcard.2004.07.050.

DOI:10.1016/j.amjcard.2004.07.050
PMID:15519287
Abstract

Surveys commissioned by the National Lipid Association (NLA) were conducted to determine the current attitudes and perceptions of physicians, consumers, and pharmacists regarding the impact of an over-the-counter (OTC) statin. Individuals from preexisting independent databases were randomly invited to participate in the online surveys that were open from January 26 to 30, 2004 for physicians and consumers and from March 1 to 12, 2004 for pharmacists. The results of these surveys indicate that consumers and pharmacists are more positive regarding the idea of an OTC statin, whereas physicians are more guarded. Concerns of both physicians and pharmacists included the discontinuation by patients of their prescription cholesterol-lowering therapy without consulting their physician, safety issues such as potential drug interactions and side effects, and patient ability to self-manage OTC statins. Consumers interested in purchasing an OTC statin reported that they would consult their physician before doing so, and pharmacists were interested in supporting consumers who use OTC statins. Although such support would require further training and time, pharmacists believed that they could facilitate consumer self-care programs and follow-up with physicians.

摘要

美国国家脂质协会(NLA)委托开展了多项调查,以确定医生、消费者和药剂师目前对非处方(OTC)他汀类药物影响的态度和看法。从现有的独立数据库中随机邀请个人参与在线调查,该调查于2004年1月26日至30日面向医生和消费者开放,于2004年3月1日至12日面向药剂师开放。这些调查结果表明,消费者和药剂师对非处方他汀类药物的看法更为积极,而医生则更为谨慎。医生和药剂师都担心患者在未咨询医生的情况下停用其处方降胆固醇疗法、潜在药物相互作用和副作用等安全问题,以及患者自我管理非处方他汀类药物的能力。有购买非处方他汀类药物意向的消费者表示,他们会在购买前咨询医生,药剂师也有意为使用非处方他汀类药物的消费者提供支持。尽管这种支持需要进一步培训和时间,但药剂师认为他们可以促进消费者自我护理计划并与医生进行跟进。

相似文献

1
The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: is this a good idea?美国国家脂质协会针对美国一种非处方他汀类药物对消费者、医生和药剂师进行的调查:这是个好主意吗?
Am J Cardiol. 2004 Nov 4;94(9A):16F-21F. doi: 10.1016/j.amjcard.2004.07.050.
2
Understanding physician and consumer attitudes concerning cholesterol management: results from the National Lipid Association surveys.
Am J Cardiol. 2004 Nov 4;94(9A):9F-15F. doi: 10.1016/j.amjcard.2004.07.047.
3
Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.生活方式类药物还是救命药物?一项关于非处方他汀类药物的初级医疗保健专业人员和消费者意见调查。
Ann Pharmacother. 2008 Mar;42(3):413-20. doi: 10.1345/aph.1K421. Epub 2008 Feb 26.
4
Consumer behavior in the setting of over-the-counter statin availability: lessons from the consumer use study of OTC Mevacor.非处方他汀类药物可获得情况下的消费者行为:来自非处方美降脂消费者使用研究的经验教训。
Am J Cardiol. 2004 Nov 4;94(9A):22F-29F. doi: 10.1016/j.amjcard.2004.07.051.
5
Potential impact on cardiovascular public health of over-the-counter statin availability.
Am J Cardiol. 2006 Mar 15;97(6):851-6. doi: 10.1016/j.amjcard.2005.10.022. Epub 2006 Jan 30.
6
[Opinions of physicians and pharmacists on problems with drugs].[医生和药剂师对药物问题的看法]
Ceska Slov Farm. 2003 Jul;52(4):159-65.
7
Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs.非处方止痛药的使用模式及公众认知:聚焦于非甾体抗炎药
J Rheumatol. 2005 Nov;32(11):2218-24.
8
A Consumer Use Study of Over-The-Counter lovastatin (CUSTOM).一项非处方洛伐他汀的消费者使用研究(CUSTOM)。
Am J Cardiol. 2004 Nov 15;94(10):1243-8. doi: 10.1016/j.amjcard.2004.08.007.
9
National survey of pharmacists about coronary heart disease, hypercholesterolemia, nonprescription statintherapy, and pharmacists' services.关于冠心病、高胆固醇血症、非处方他汀类药物治疗以及药剂师服务的全国药剂师调查。
J Am Pharm Assoc (2003). 2004 Sep-Oct;44(5):562-8. doi: 10.1331/1544-3191.44.5.562.mckenney.
10
Physician-patient and pharmacist-patient communication: geriatrics' perceptions and opinions.医患及药剂师与患者的沟通:老年医学的认知与观点。
Patient Educ Couns. 2008 May;71(2):265-84. doi: 10.1016/j.pec.2008.01.004. Epub 2008 Mar 4.

引用本文的文献

1
Over-the-counter medicines: Global perspective and Indian scenario.非处方药:全球视角与印度情况
J Postgrad Med. 2020 Jan-Mar;66(1):28-34. doi: 10.4103/jpgm.JPGM_381_19.
2
Patient attitudes towards a new role for pharmacists: continued dispensing.患者对药剂师新职责(持续配药)的态度。
Patient Prefer Adherence. 2014 Aug 27;8:1143-51. doi: 10.2147/PPA.S66719. eCollection 2014.
3
The Food and Drug Administration and over-the-counter statins: an opportunity lost?美国食品药品监督管理局与非处方他汀类药物:错失的机遇?
J Clin Hypertens (Greenwich). 2008 Mar;10(3):245-8. doi: 10.1111/j.1751-7176.2008.08047.x.
4
Community pharmacists' views, attitudes and early experiences of over-the-counter simvastatin.社区药剂师对非处方辛伐他汀的看法、态度及早期体验
Pharm World Sci. 2007 Aug;29(4):380-5. doi: 10.1007/s11096-007-9084-4. Epub 2007 Mar 15.
5
Should cholesterol-lowering medications be available in Canada without a prescription?在加拿大,降胆固醇药物是否应该无需处方就能买到?
Can J Cardiol. 2007 Mar 1;23(3):189-93. doi: 10.1016/s0828-282x(07)70742-0.
6
American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.美国、英国和欧洲关于他汀类药物用于心血管疾病一级预防的建议应用于对英国男性的前瞻性研究。
Heart. 2006 Sep;92(9):1213-8. doi: 10.1136/hrt.2005.085183. Epub 2006 May 22.
7
Over-the-counter statin therapy--pros and cons.非处方他汀类药物治疗——利弊
J Clin Hypertens (Greenwich). 2005 May;7(5):262, 299. doi: 10.1111/j.1524-6175.2005.04113.x.